Natural rubber latex (NRL) is the cytoplasmic latex of laticifer cells from the rubber tree, Hevea brasiliensis. It is an industrially valuable material because its rubber particles contain cis-1,4-polyisoprene and associated proteins that support rubber biosynthesis and latex flow. In finished products, however, NRL is not simply “rubber.” It is a processed biological material whose allergenic potential depends on the source latex, protein composition, manufacturing steps, leaching, vulcanization, chlorination, glove powder, residual extractable proteins, and route of exposure (Katelaris, 2022; NIOSH, 1997).
Current allergen nomenclature recognizes 15 H. brasiliensis allergens, Hev b 1 through Hev b 15. These proteins are not interchangeable clinically. Some are rubber-particle-associated structural or biosynthetic proteins, some are soluble latex proteins, and others are plant defense or “pathogenesis-related” proteins with homologs in fruits, vegetables, pollens, fungi, or other plants. This explains why one latex-allergic patient may react mainly through direct mucosal contact or medical procedures, another through inhaled powdered-glove particles, and another through latex-associated plant foods (Katelaris, 2022; WHO/IUIS Allergen Nomenclature Sub-Committee, n.d.).
Material-science relevance: Why products differ in allergenicity
Manufactured latex products differ widely in allergen exposure. Medical gloves historically became a major exposure source because water-soluble latex proteins could adsorb onto cornstarch powder, become aerosolized, and then contact the conjunctiva, nose, respiratory tract, or inflamed skin. Powder-free, low-protein gloves, improved leaching, chlorination, substitution with synthetic gloves, and latex-safe workplace policies sharply reduced occupational exposure. The FDA banned powdered surgeon’s gloves, powdered patient examination gloves, and absorbable powder for lubricating surgeon’s gloves in the United States effective January 18, 2017, after concluding that the risks could not be adequately mitigated by labeling alone (FDA, 2016; Katelaris, 2022; NIOSH, 1997).
This material distinction is clinically important. Synthetic “latex” materials do not contain H. brasiliensis proteins and therefore do not cause IgE-mediated natural rubber latex protein allergy, although they may still cause irritant dermatitis or allergic contact dermatitis from chemical additives. Conversely, natural rubber products may contain both protein allergens and chemical accelerators, antioxidants, or vulcanization residues. Thus, “latex reaction” should be clarified as irritant dermatitis, type IV allergic contact dermatitis to rubber chemicals, or type I IgE-mediated allergy to NRL proteins (Katelaris, 2022; NIOSH, 1997).
Immunologic mechanisms and routes of exposure
NRL reactions fall into three broad categories. Irritant contact dermatitis is nonimmune barrier injury. Allergic contact dermatitis is a delayed, T-cell-mediated reaction, commonly to rubber accelerators such as thiurams, carbamates, mercaptobenzothiazoles, or related chemicals. IgE-mediated latex allergy is immediate hypersensitivity to NRL proteins and can cause contact urticaria, angioedema, rhinitis, conjunctivitis, asthma, perioperative anaphylaxis, or anaphylaxis from mucosal exposure to latex-containing devices (Katelaris, 2022).
Risk is highest in people with intense or repeated exposure. Historically high-risk groups include health-care workers, dental workers, workers in latex manufacturing, patients with spina bifida, patients undergoing multiple surgeries, and individuals with atopy or hand dermatitis. Spina bifida and multiple-surgery patients are often sensitized through mucosal or parenteral routes, whereas health-care workers have often been sensitized through skin contact and inhalation of aerosolized glove-powder particles (Katelaris, 2022).
Plant physiology and why many latex allergens are defense proteins
Latex is part of the plant’s defense and wound-response system. Several Hev b allergens are enzymes or defense-related proteins, including beta-1,3-glucanase, hevein/prohevein, chitinases, patatin-like proteins, lipid-transfer proteins, and hevamine. These proteins help the plant respond to fungi, insects, tissue injury, and latex coagulation. Because many plant defense proteins are evolutionarily conserved, homologous structures occur in botanically related and unrelated foods, pollens, and molds. This conservation is one reason latex allergy can overlap with fruit, vegetable, pollen, or mold sensitization (Wang et al., 2015; Sharma & Vitte, 2024).
Plant stress and agricultural stimulation can change latex composition. For example, ethylene stimulation is used to increase rubber yield and can alter laticifer metabolism, rubber particle populations, and the abundance or phosphorylation of proteins such as rubber elongation factor, small rubber particle protein, hevein, glucanase, enolase, Mn-superoxide dismutase, and other latex proteins. The practical implication is not that stress automatically increases allergy risk, but that latex allergenicity is a product-specific and protein-specific property that should be assessed empirically (Wang et al., 2015).
Cross-reactivity and latex-fruit syndrome
Cross-reactivity occurs when IgE antibodies or T cells generated against one allergen recognize a sufficiently similar epitope on another molecule. In latex-fruit syndrome, IgE to latex allergens may recognize homologous plant-food proteins. The most consistently reported high-association foods include banana, avocado, chestnut, and kiwifruit. Papaya, tomato, potato, apple, carrot, celery, melons, peach, and other foods are reported less consistently or with more variable clinical relevance. Importantly, a positive IgE test or sequence similarity does not prove that a patient will have symptoms after eating a food; clinical history and, when appropriate, supervised testing are needed (Allergy & Asthma Network, n.d.; Gromek et al., 2024).
Latex-food cross-reactivity is driven mainly by several protein families. Hevein and hevein-like domains in class I chitinases are central to reactions involving banana, avocado, chestnut, and kiwi. Profilins, including Hev b 8, are panallergens shared by pollens and many plant foods and often indicate broad cross-sensitization rather than clinically severe latex allergy. Nonspecific lipid-transfer proteins, glucanases, and other defense proteins may also contribute to individual reaction patterns (Ganglberger et al., 2001; Sharma & Vitte, 2024).
Component-resolved allergen summary
The table below uses current WHO/IUIS nomenclature and summarizes the major clinical implications. Food associations should be interpreted as reported cross-reactivity patterns, not as universal avoidance lists. Official names and designations are from WHO/IUIS; clinical interpretation is synthesized from WAO guidance, latex-fruit syndrome reviews, and molecular allergology literature.
| Allergen | Protein/function | Clinical and cross-reactivity notes |
|---|---|---|
| Hev b 1 | Rubber elongation factor; rubber-particle-associated; involved in rubber biosynthesis | Major marker in spina bifida and multiple-surgery patients, especially with mucosal/parenteral exposure. Less associated with airborne glove-powder exposure because it is rubber-particle-bound rather than highly soluble. |
| Hev b 2 | Beta-1,3-glucanase; plant defense/pathogenesis-related protein | Reported cross-reactivity with plant glucanases. Recent molecular reviews describe novel cross-reactivity between Hev b 2 and banana Mus a 5 and Japanese cedar pollen CJP38. |
| Hev b 3 | Small rubber particle protein; rubber biosynthesis | Clinically important in spina bifida and repeated-surgery populations. Partial functional and immunologic overlap with Hev b 1 because both are rubber-particle-associated proteins. |
| Hev b 4 | Lecithinase/GDSL lipase-esterase family protein; historically described as part of a microhelix complex | Less commonly emphasized in component-resolved clinical algorithms than Hev b 1, 3, 5, 6, and 8. Avoid overclaiming specific food cross-reactivity unless supported by patient-level testing. |
| Hev b 5 | Acidic latex protein; soluble latex allergen | Major occupational allergen, especially in health-care workers. More relevant to inhalation and glove-powder exposure than rubber-particle-bound proteins. Reported latex-food links include manioc/cassava homolog Man e 5 and Rosaceae homologs such as apricot Pru ar 5. |
| Hev b 6.01 | Prohevein, the hevein precursor | Major latex allergen and key contributor to latex-fruit syndrome. Involved in plant defense and latex coagulation. |
| Hev b 6.02 | Mature hevein, N-terminal domain of prohevein | One of the most important latex-fruit syndrome allergens. Cross-reacts with hevein-like domains in class I chitinases from banana, avocado, chestnut, kiwi, and related plant foods. |
| Hev b 6.03 | C-terminal fragment of prohevein | Should be spelled “mature” rather than “marure” in the draft. It may be relevant in glove-associated exposure, but Hev b 6.02 carries much of the clinically important hevein-domain cross-reactivity. |
| Hev b 7 | Patatin-like protein | A plant defense-related protein. Potato and tomato associations are reported historically, but clinical relevance varies. Use “patatin-like,” not “palatin-like.” |
| Hev b 8 | Profilin; actin-binding cytoskeletal protein | Panallergen shared with pollens and many plant foods. Hev b 8 sensitization can indicate pollen/plant-food profilin cross-reactivity and may be associated with positive latex IgE tests without clinically important latex reactions. |
| Hev b 9 | Enolase; glycolytic enzyme | Cross-reactivity with fungal enolases has been reported and is sometimes discussed in latex-mold sensitization, but clinical relevance should be judged case by case. |
| Hev b 10 | Manganese superoxide dismutase | Potential cross-reactivity with fungal Mn-superoxide dismutases has been described; clinical importance is variable. |
| Hev b 11 | Class I chitinase | Plant defense enzyme. May overlap immunologically with hevein-domain cross-reactivity patterns, although it is distinct from Hev b 6. |
| Hev b 12 | Nonspecific lipid-transfer protein type 1 | Member of a broadly distributed plant panallergen family. Potential cross-reactivity with fruits, cereals, vegetables, and pollens should be interpreted in the patient’s broader LTP sensitization context. |
| Hev b 13 | Esterase | Current WHO/IUIS still lists Hev b 13 as a separate esterase allergen. Do not state that it has been fully reclassified as Hev b 7.02 unless discussing older nomenclature confusion. |
| Hev b 14 | Hevamine | Plant defense-associated protein. Reported food associations are less clinically established than for Hev b 6, Hev b 8, or Hev b 12. |
| Hev b 15 | Serine protease inhibitor | Add to the article. It is recognized in WHO/IUIS nomenclature, but it is not yet as central in routine clinical interpretation as Hev b 1, 3, 5, 6, or 8. |
Diagnostic implications
A generic “latex allergen test” is difficult because latex allergy is not a single-molecule disease. Whole-extract testing can detect sensitization but may not distinguish clinically important NRL allergy from cross-reactivity to panallergens such as profilin or cross-reactive carbohydrate determinants. Component-resolved diagnostics can improve interpretation by identifying patterns such as Hev b 1/3 sensitization in spina bifida or multiple-surgery patients, Hev b 5/6 sensitization in occupational latex allergy, and Hev b 8 sensitization in pollen/plant-food profilin cross-reactivity (Katelaris, 2022; Sharma & Vitte, 2024).
In countries where standardized skin-prick testing extracts are available, skin testing plus a careful exposure history is often central to diagnosis. In the United States, standardized FDA-approved latex skin-test reagents have not been available, so clinicians often rely on clinical history, serum specific IgE testing, component-resolved testing where available, and avoidance/provocation decisions made by allergy specialists. Provocation testing may be hazardous and is generally not used casually (Katelaris, 2022).
Management and prevention
Management is primarily exposure reduction. In health-care and occupational settings, nonlatex gloves should be used when latex is not required, and reduced-protein, powder-free latex gloves should be used when latex is necessary. Latex-safe environments, avoidance of powdered latex products, clear medical documentation, patient education, and emergency preparedness are important for patients with confirmed IgE-mediated latex allergy. Patients with systemic reactions should discuss epinephrine autoinjector use and perioperative precautions with their clinician (Katelaris, 2022; NIOSH, 1997).
Food avoidance should be individualized. People with latex allergy do not need to avoid every food that has ever been reported as cross-reactive. The strongest recurring associations are banana, avocado, chestnut, and kiwi, but reactions vary widely. Patients should avoid foods that have caused symptoms and seek allergy evaluation for unclear, systemic, or high-risk reactions (Gromek et al., 2024; Allergy & Asthma Network, n.d.).
Food/cross-reactivity
Latex-fruit syndrome refers to clinically relevant cross-reactivity between IgE antibodies to NRL proteins and homologous proteins in plant foods. The most consistently implicated foods are banana, avocado, chestnut, and kiwifruit. Other foods reported with variable or lower-frequency associations include papaya, tomato, potato, apple, carrot, celery, melon, peach, fig, passion fruit, mango, pineapple, cassava/manioc, bell pepper, zucchini, pumpkin, turnip, soybean, wheat, and others. These lists should be treated as risk-association lists rather than avoidance lists; clinical relevance depends on symptoms, component sensitization, and patient history.
References
Allergy & Asthma Network. (n.d.). Latex allergy and foods. https://allergyasthmanetwork.org/allergies/latex-allergy/latex-allergy-foods/
American Latex Allergy Association. (n.d.). Latex cross-reactive foods fact sheet. https://latexallergyresources.org/latex-cross-reactive-foods-fact-sheet
Blanco, C., Carrillo, T., Castillo, R., Quiralte, J., & Cuevas, M. (1994). Latex allergy: Clinical features and cross-reactivity with fruits. Annals of Allergy, 73(4), 309–314.
Food and Agriculture Organization of the United Nations/World Health Organization. (2001). Evaluation of allergenicity of genetically modified foods: Report of a Joint FAO/WHO Expert Consultation on Allergenicity of Foods Derived from Biotechnology. FAO. https://www.fao.org/4/y0820e/y0820e06.htm
Food and Drug Administration. (2016). Banned devices; powdered surgeon’s gloves, powdered patient examination gloves, and absorbable powder for lubricating a surgeon’s glove; final rule. Federal Register, 81(243), 91722–91734. https://www.federalregister.gov/documents/2016/12/19/2016-30382/banned-devices-powdered-surgeons-gloves-powdered-patient-examination-gloves-and-absorbable-powder
Ganglberger, E., Radauer, C., Wagner, S., Ó Ríordáin, G., Beezhold, D. H., Brehler, R., Niggemann, B., Scheiner, O., Jensen-Jarolim, E., & Breiteneder, H. (2001). Hev b 8, the Hevea brasiliensis latex profilin, is a cross-reactive allergen of latex, plant foods and pollen. International Archives of Allergy and Immunology, 125(3), 216–227. https://doi.org/10.1159/000053819
Grier, T. (2015, October). The why behind latex and cross-reactive foods. Allergy & Asthma Network.
Gromek, W., Kołdej, N., Świtała, S., Majsiak, E., & Kurowski, M. (2024). Revisiting latex-fruit syndrome after 30 years of research: A comprehensive literature review and description of two cases. Journal of Clinical Medicine, 13(14), Article 4222. https://doi.org/10.3390/jcm13144222
Katelaris, C. (2022, January). Latex allergy diagnosis and management. World Allergy Organization. https://www.worldallergy.org/component/content/article/newly-updated-latex-allergy-diagnosis-and-management-katelaris-c-updated-2022
Midoro-Horiuti, T., Brooks, E. G., & Goldblum, R. M. (2001). Pathogenesis-related proteins of plants as allergens. Annals of Allergy, Asthma & Immunology, 87(4), 261–271.
National Institute for Occupational Safety and Health. (1997). Preventing allergic reactions to natural rubber latex in the workplace (DHHS [NIOSH] Publication No. 97-135). Centers for Disease Control and Prevention. https://www.cdc.gov/niosh/docs/97-135/
Nucera, E., Aruanno, A., Rizzi, A., & Centrone, M. (2020). Latex allergy: Current status and future perspectives. Journal of Asthma and Allergy, 13, 385–398. https://doi.org/10.2147/JAA.S242058
Parisi, C. A. S., Kelly, K. J., Ansotegui, I. J., González-Díaz, S. N., Bilò, M. B., Cardona, V., Park, H.-S., Braschi, M. C., Macias-Weinmann, A., Piga, M. A., Acuña-Ortega, N., Sánchez-Borges, M., & Yañez, A. (2021). Update on latex allergy: New insights into an old problem. World Allergy Organization Journal, 14(8), Article 100569. https://doi.org/10.1016/j.waojou.2021.100569
Sharma, E., & Vitte, J. (2024). A systematic review of allergen cross-reactivity: Translating basic concepts into clinical relevance. JACI Global, 3(2), Article 100230. https://doi.org/10.1016/j.jacig.2024.100230
Wang, X., Wang, D., Sun, Y., Yang, Q., Chang, L., Wang, L., Meng, X., Huang, Q., Jin, X., & Tong, Z. (2015). Comprehensive proteomics analysis of laticifer latex reveals new insights into ethylene stimulation of natural rubber production. Scientific Reports, 5, Article 13778. https://doi.org/10.1038/srep13778
WHO/IUIS Allergen Nomenclature Sub-Committee. (n.d.). Allergen search results: Hevea brasiliensis. Allergen Nomenclature. Retrieved June 18, 2026, from https://www.allergen.org/search.php?Species=Hevea+brasiliensis
Yagami, T., Sato, M., Nakamura, A., Komiyama, T., Kitagawa, K., Akasawa, A., & Ikezawa, Z. (1998). Plant defense-related enzymes as latex antigens. Journal of Allergy and Clinical Immunology, 101(3), 379–385.
Appendix I: Change Modification Log
17 JUN 26 - Enhanced article with more literature review.